Dinutuximab
ANBL1821
Phase 2 mab active
Quick answer
Dinutuximab for High Risk Neuroblastoma is a Phase 2 program (mab) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Children's Hospital of Fudan University
- Indication
- High Risk Neuroblastoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active